0.35
+9.37%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Biome Australia
Its shares trade on ASX under the ticker BIO.AX. It has been listed since 30 November 2021. In the fiscal year to 30 June 2026, it reported revenue of A$23.9m and net income of A$3.6m. At that date it held total assets of A$15.7m and shareholders' equity of A$9.4m.
Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. The company develops, licenses, commercializes and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products are marketed under three brands: Activated Probiotics, Activated Nutrients and Activated X Performance. Its products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The firm distributes its products in Australia, New Zealand and the United Kingdom. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trails.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 30 Nov 2021
- Employees
- 30
- Website
- biomeaustralia.com ↗
Leadership
Pay as last reported
- Mr. Geoffrey SamChairman of the Board, since 2024
- Mr. Chee Yong LohChief Financial Officer, since 2021A$485,686
- Mr. Blair William Brabin Vega NorfolkManaging Director, Director, since 2018A$772,690
- Mr. George LazarouCompany Secretary
- Ms. Dominique FisherNon-Executive Independent DirectorA$79,179
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Biome Australia Ltd has a clear focus on evidence-based products linking gut health and human health.
- The company operates with three distinct product brands: Activated Probiotics, Activated Nutrients, and Activated X Performance.
- It distributes products through multiple channels including community pharmacies, health practitioners, and online direct to consumers.
Weaknesses
- The company has a small employee count of 30, which may limit operational capacity.
- Biome Australia Ltd is a relatively new company, having gone public in 2021.
- The company's product range is limited to specific health concerns without broader diversification.
Opportunities
- Expanding distribution into new international markets beyond Australia, New Zealand, and the UK.
- Increasing market share in the growing nutraceutical and probiotic industry.
- Leveraging clinical research to develop new products for additional health concerns.
Threats
- Competition from established players in the nutraceutical and probiotic markets.
- Regulatory challenges in the development and marketing of complementary medicines.
- Dependence on strategic partners for product development and commercialization.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.